Kite Pharma, Inc. Deferred Revenue
Kite Pharma, Inc. had Deferred Revenue of $42.19 million as of 2017-06-30, per its 10-Q filed 2017-08-08.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DeferredRevenueCurrent · last filed 2017-08-08
- 2017-06-30: Deferred Revenue, Current $42.19M.
- 2017-03-31: Deferred Revenue, Current $39.89M.
- 2016-12-31: Deferred Revenue, Current $15.00M.
- 2016-09-30: Deferred Revenue, Current $15.08M.
| Period end | Deferred Revenue, Current |
|---|---|
| 2017-06-30 | $42.19M 10-Q · filed 2017-08-08 |
| 2017-03-31 | $39.89M 10-Q · filed 2017-05-08 |
| 2016-12-31 | $15.00M 10-Q · filed 2017-08-08 |
| 2016-09-30 | $15.08M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $16.17M 10-Q · filed 2016-08-08 |
| 2016-03-31 | $16.25M 10-Q · filed 2016-05-09 |
| 2015-12-31 | $16.33M 10-K · filed 2017-02-28 |
| 2015-09-30 | $15.33M 10-Q · filed 2015-11-12 |
| 2015-06-30 | $15.00M 10-Q · filed 2015-08-10 |
| 2015-03-31 | $15.00M 10-Q · filed 2015-05-15 |